HCW Biologics Inc.
HCWB | NASDAQ
$1.91
+$0.04 (+2.14%)
At close: Sep 21, 2026, 4:00 PM ET
$1.97
+$0.06 (+3.07%)
Pre-market:
Sep 22, 2026, 4:38 AM ET
Market Data
Market Cap $650.09K
Enterprise Value $6.48M
Beta 2.38
Average Volume 2.05M
Shares Outstanding (Diluted) 1.33M
Shares Change YoY 347.6%
Institutional Ownership 21.44%
Exchange NASDAQ
ISIN US40423R3030
Price Performance
Price Change 1M -17.7%
Price Change 3M -70.5%
Price Change 6M -18.4%
Price Change YTD -71.6%
Price Change 1Y -92.1%
Price Change 3Y -99.6%
Price Change 5Y -99.8%
1M CAGR (ann.) -45.2%
1Y CAGR (ann.) -92.8%
5Y CAGR (ann.) -71.7%
All-Time CAGR -72.6%
Valuation
PE Ratio -0.09
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio 0.10
Forward PS 0.00
PB Ratio 0.09
P/FCF Ratio -0.05
P/Adj. FCF Ratio -0.05
P/OCF Ratio -0.06
EV/Sales 0.96
EV/EBIT 28.51
EV/EBITDA -2.63
EV/FCF -0.53
Earnings Yield -1140.3%
FCF Yield -1827.8%
Adj. FCF Yield -1830.9%
Financial Health
Net Debt $5.82M
Total Debt $6.56M
Cash & Short-Term Investments $741.32K
Total Assets $26.77M
Current Ratio 0.06
Quick Ratio 0.06
Debt / Equity Ratio 0.88
Debt / EBITDA -2.66
Debt / FCF -0.54
OCF / Debt -1.85
Interest Coverage -17.08
Altman Z-Score -6.25
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 95.9%
Operating Profit Margin -91.6%
EBITDA Margin -63.6%
Net Profit Margin -73.2%
FCF Margin -180.6%
Adj. FCF Margin -180.9%
SBC / Revenue 0.3%
SBC Impact (per share) -0.2%
Returns
Return on Assets -18.4%
Return on Equity -142.2%
Return on Invested Capital -39.3%
Return on Capital Employed -75.8%
Return on Tangible Assets -18.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 20.8%
Revenue CAGR 5Y 10.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -33.2%
EPS CAGR 5Y -51.3%
EPS CAGR 10Y N/A
FCF CAGR 3Y 32.6%
FCF CAGR 5Y 10.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y 30.6%
Revenue Growth Next 3Y -90.2%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $5
Price Target Upside 161.8%
Cash Flow
Operating Cash Flow $-12.14M
Free Cash Flow $-12.14M
Adj. Free Cash Flow $-12.16M
FCF Per Share -$34.71
OCF Per Share -$34.71
OCF/S Ratio -180.6%
Income Statement
Revenue $6.72M
Gross Profit $6.45M
Operating Income $-6.15M
EBITDA $-2.47M
Net Income $-15.08M
EPS (Diluted) -$21.78
Revenue / Employee $192.03K
Profit / Employee $-430.75K
Employees 35
Add to Watchlist
Select watchlists to add or remove HCWB